Cargando…
NLRX1 Modulates Immunometabolic Mechanisms Controlling the Host–Gut Microbiota Interactions during Inflammatory Bowel Disease
Interactions among the gut microbiome, dysregulated immune responses, and genetic factors contribute to the pathogenesis of inflammatory bowel disease (IBD). Nlrx1(−/−) mice have exacerbated disease severity, colonic lesions, and increased inflammatory markers. Global transcriptomic analyses demonst...
Autores principales: | Leber, Andrew, Hontecillas, Raquel, Tubau-Juni, Nuria, Zoccoli-Rodriguez, Victoria, Abedi, Vida, Bassaganya-Riera, Josep |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834749/ https://www.ncbi.nlm.nih.gov/pubmed/29535731 http://dx.doi.org/10.3389/fimmu.2018.00363 |
Ejemplares similares
-
Modeling-Enabled Characterization of Novel NLRX1 Ligands
por: Lu, Pinyi, et al.
Publicado: (2015) -
Nlrx1-Regulated Defense and Metabolic Responses to Aspergillus fumigatus Are Morphotype and Cell Type Specific
por: Kastelberg, Bridget, et al.
Publicado: (2021) -
NLRX1 is a key regulator of immune signaling during invasive pulmonary aspergillosis
por: Kastelberg, Bridget, et al.
Publicado: (2020) -
Modulation of colonic immunometabolic responses during Clostridioides difficile infection ameliorates disease severity and inflammation
por: Tubau-Juni, Nuria, et al.
Publicado: (2023) -
High-resolution computational modeling of immune responses in the gut
por: Verma, Meghna, et al.
Publicado: (2019)